Fmoc-L-glutamic acid α-allyl ester

Fmoc-L-glutamic acid α-allyl ester is an Fmoc-protected L-glutamate derivative in which the α-carboxyl group is esterified as an allyl ester while the α-amino function is masked with the base-labile Fmoc carbamate. The molecule retains the glutamate side-chain carboxylate as a functional handle for orthogonal protection and selective peptide coupling, and it bears a stereogenic center at the glutamate α-position consistent with L-configuration. The allyl ester introduces a removable protecting element that can undergo chemoselective deprotection under conditions compatible with many peptide-synthesis workflows, while the Fmoc group supports standard base-mediated unmasking of the amino terminus. The combination of an Fmoc-protected N-terminus, an allyl-ester C-terminal motif, and glutamate's two carboxyl groups makes this compound a chiral, multifunctional intermediate for protected amino acid synthesis, peptide building block preparation, and downstream functionalization.

1. Peptide Synthesis

Fmoc-L-glutamic acid α-allyl ester supports peptide coupling chemistry in solid-phase peptide synthesis and solution-phase assembly by providing an Fmoc-protected amino group for controlled N-terminal activation and deprotection. The glutamate framework presents a side-chain carboxyl functionality that can be orthogonally protected to manage selective coupling and prevent undesired amide formation during chain elongation. The allyl ester at the α-carboxyl position serves as a C-terminal protecting strategy that can be removed to generate a carboxylic acid for subsequent conjugation or for incorporation into longer peptide sequences with defined termini. The stereochemical integrity of the L-glutamate center enables predictable incorporation into peptide backbones and peptidomimetic scaffolds where glutamate geometry affects conformational preferences and recognition. This amino acid ester therefore functions as a practical protected glutamate building block for constructing peptide segments and terminally functionalized derivatives.

2. Side-Chain Functionalization

Fmoc-L-glutamic acid α-allyl ester is well suited to amino acid derivatization and side-chain engineering workflows that require orthogonal functional-group manipulation on glutamate. The allyl ester can be used as a temporary C-terminal protection element, while the glutamate side-chain carboxyl group enables formation of amides, esters, or activated intermediates for downstream attachment chemistry. The presence of the Fmoc carbamate allows the compound to be handled as a stable chiral intermediate during multistep synthesis, with later Fmoc removal enabling access to a free amino functionality for controlled coupling or derivatization. The allyl motif can be transformed into carboxylic acid functionality after deprotection, enabling generation of defined termini for further functional group installation. Broader synthetic utility arises from combining chiral amino acid stereochemistry with orthogonal protection patterns that are compatible with iterative functionalization of peptide-like molecules.

3. Peptidomimetics And SAR Studies

Fmoc-L-glutamic acid α-allyl ester can be applied in peptidomimetic construction and structure-activity relationship studies where glutamate-like acidic motifs are used to tune binding interactions. The glutamate backbone provides two carboxyl-derived functional sites, enabling systematic variation of charge presentation through selective deprotection and subsequent conversion to amide or ester analogs. The Fmoc-protected amino group supports incorporation into protected peptide fragments that can later be unmasked to generate defined analogs for SAR mapping. The allyl ester strategy supports controlled generation of a carboxyl terminus that can participate in salt-bridge formation or be modified to probe steric and electronic effects in receptor-binding models. This makes the compound useful as a chiral, protection-compatible intermediate for generating libraries of glutamate-containing analogs used in medicinal chemistry research and molecular design campaigns.

4. Bioconjugation Chemistry

Fmoc-L-glutamic acid α-allyl ester is suitable for biomolecule modification routes that require a glutamate-derived acidic linker with orthogonal protection for stepwise conjugation. The allyl ester can be employed to mask the α-carboxyl group during initial coupling steps, then converted to a free carboxylic acid to enable subsequent activation and attachment to amine-bearing biomolecules or to surfaces. The Fmoc group provides a stable N-protected handle during synthesis of conjugation-ready intermediates, with base-mediated removal enabling controlled formation of amide bonds or further linker elaboration. The stereodefined L-glutamate scaffold can be used to introduce consistent spatial arrangement of acidic functionalities that influence linker length, local charge density, and conjugate solubility. Downstream utility includes preparation of peptide-based linkers, glutamate-containing conjugates, and analytical standards that support characterization of conjugation chemistry in biochemical research workflows.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-glutamic acid α-allyl ester fits pharmaceutical intermediate preparation needs where protected amino acid derivatives are required for scalable peptide building block synthesis and controlled functional-group presentation. The Fmoc carbamate enables reliable handling of the amino functionality under manufacturing-friendly conditions, while the allyl ester provides an orthogonal C-terminal protection element that can be removed without disturbing the N-protecting strategy. The glutamate di-functional character supports downstream conversion into activated carboxylic acid forms or amide-forming derivatives used in manufacturing of peptide intermediates and peptidomimetic precursors. The defined stereochemistry at the α-carbon supports reproducible incorporation into peptide sequences and reduces ambiguity in chiral identity during process development. This compound therefore serves as a process-compatible chiral intermediate for fine chemical synthesis and peptide-related manufacturing where protection/deprotection logic is central to route design.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

3. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

4. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

5. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide